These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exonic deletions of FXN and early-onset Friedreich ataxia. Anheim M; Mariani LL; Calvas P; Cheuret E; Zagnoli F; Odent S; Seguela C; Marelli C; Fritsch M; Delaunoy JP; Brice A; Dürr A; Koenig M Arch Neurol; 2012 Jul; 69(7):912-6. PubMed ID: 22409940 [TBL] [Abstract][Full Text] [Related]
3. Idebenone in patients with Friedreich ataxia. Schöls L; Vorgerd M; Schillings M; Skipka G; Zange J Neurosci Lett; 2001 Jun; 306(3):169-72. PubMed ID: 11406322 [TBL] [Abstract][Full Text] [Related]
4. Clinical experience with high-dose idebenone in Friedreich ataxia. Schulz JB; Di Prospero NA; Fischbeck K J Neurol; 2009 Mar; 256 Suppl 1(0 1):42-5. PubMed ID: 19283350 [TBL] [Abstract][Full Text] [Related]
5. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Hart PE; Lodi R; Rajagopalan B; Bradley JL; Crilley JG; Turner C; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM Arch Neurol; 2005 Apr; 62(4):621-6. PubMed ID: 15824263 [TBL] [Abstract][Full Text] [Related]
6. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA). Lagedrost SJ; Sutton MS; Cohen MS; Satou GM; Kaufman BD; Perlman SL; Rummey C; Meier T; Lynch DR Am Heart J; 2011 Mar; 161(3):639-645.e1. PubMed ID: 21392622 [TBL] [Abstract][Full Text] [Related]
7. Exercise capacity and idebenone intervention in children and adolescents with Friedreich ataxia. Drinkard BE; Keyser RE; Paul SM; Arena R; Plehn JF; Yanovski JA; Di Prospero NA Arch Phys Med Rehabil; 2010 Jul; 91(7):1044-50. PubMed ID: 20599042 [TBL] [Abstract][Full Text] [Related]
8. Antioxidants and other pharmacological treatments for Friedreich ataxia. Kearney M; Orrell RW; Fahey M; Pandolfo M Cochrane Database Syst Rev; 2012 Apr; (4):CD007791. PubMed ID: 22513953 [TBL] [Abstract][Full Text] [Related]
9. Idebenone in Friedreich's ataxia. Tonon C; Lodi R Expert Opin Pharmacother; 2008 Sep; 9(13):2327-37. PubMed ID: 18710357 [TBL] [Abstract][Full Text] [Related]
10. Antioxidants and other pharmacological treatments for Friedreich ataxia. Kearney M; Orrell RW; Fahey M; Pandolfo M Cochrane Database Syst Rev; 2009 Oct; (4):CD007791. PubMed ID: 19821439 [TBL] [Abstract][Full Text] [Related]
11. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial. Di Prospero NA; Baker A; Jeffries N; Fischbeck KH Lancet Neurol; 2007 Oct; 6(10):878-86. PubMed ID: 17826341 [TBL] [Abstract][Full Text] [Related]
12. Clinical Experience With Deferiprone Treatment for Friedreich Ataxia. Elincx-Benizri S; Glik A; Merkel D; Arad M; Freimark D; Kozlova E; Cabantchik I; Hassin-Baer S J Child Neurol; 2016 Jul; 31(8):1036-40. PubMed ID: 27029487 [TBL] [Abstract][Full Text] [Related]
13. Triple therapy with darbepoetin alfa, idebenone, and riboflavin in Friedreich's ataxia: an open-label trial. Arpa J; Sanz-Gallego I; Rodríguez-de-Rivera FJ; Domínguez-Melcón FJ; Prefasi D; Oliva-Navarro J; Moreno-Yangüela M; Pascual-Pascual SI Cerebellum; 2013 Oct; 12(5):713-20. PubMed ID: 23625326 [TBL] [Abstract][Full Text] [Related]
14. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia. Lynch DR; Perlman SL; Meier T Arch Neurol; 2010 Aug; 67(8):941-7. PubMed ID: 20697044 [TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia. Di Prospero NA; Sumner CJ; Penzak SR; Ravina B; Fischbeck KH; Taylor JP Arch Neurol; 2007 Jun; 64(6):803-8. PubMed ID: 17562928 [TBL] [Abstract][Full Text] [Related]
16. Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up. Ribaï P; Pousset F; Tanguy ML; Rivaud-Pechoux S; Le Ber I; Gasparini F; Charles P; Béraud AS; Schmitt M; Koenig M; Mallet A; Brice A; Dürr A Arch Neurol; 2007 Apr; 64(4):558-64. PubMed ID: 17420319 [TBL] [Abstract][Full Text] [Related]